|
Biz Break: Gilead pins hopes on HIV drug; Apple rumors; and chipmakers' outlook improves
Posted on May 11, 2012 at 17:24 PM EDT
Today: Approval of a drug that prevents HIV infection could bring $4 billion in yearly sales for Foster City-based Gilead Sciences. Plus, Foxconn CEO talks about Apple TV, Apple may drop Google Maps and Silicon Valley stocks help Wall Street offset banking losses.
Don't Miss Gains in KO, EQR, GILD and CMCSA
Today 13:00 EDT
about
GILD
about
GILD
about
GILD
EMA Approves MAA for Gilead's (GILD) Sofosbuvir
May 21, 2013
about
GILD
European Medicines Agency Validates Gilead’s Marketing Application for Sofosbuvir for the Treatment of Hepatitis C
May 21, 2013
about
GILD
from PR Newswire
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes. Markets are closed on certain holidays. Stock Market Holiday List By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. Press Release Service provided by PRConnect. Stock quotes supplied by Telekurs USA Postage Rates Bots go here |
| ||||||
|
|
| ||||||